[ Price : $8.95]
FDA warns Mylan about CGMP deviations in producing active pharmaceutical ingredients at one of its facilities in India.[ Price : $8.95]
FDA warns Acella Pharmaceuticals about CGMP and other violations in its production of finished drugs.[ Price : $8.95]
Two drug company stakeholders respond to an FDA draft guidance on Orange Book questions and answers.[ Price : $8.95]
Attorney Jeffrey Shapiro discusses reasons why HHS made the right decision in ordering FDA to abstain from the premarket review of...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes Acella Pharmaceuticals, Mylan and Revival Products.[ Price : $8.95]
An assessment finds that combination product review practices are generally efficient and effective and need only minor adjustment...[ Price : $8.95]
The Justice Department says the former Indivior global medical director has pleaded guilty to a single misdemeanor charge of intro...[ Price : $8.95]
FDA issues a guidance to help manufacturers prevent unacceptable levels of nitrosamines in all chemically synthesized drugs.